EMBO Molecular Medicine

Papers
(The H4-Index of EMBO Molecular Medicine is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Whole‐brain microscopy reveals distinct temporal and spatial efficacy of anti‐Aβ therapies222
IQCN disruption causes fertilization failure and male infertility due to manchette assembly defect180
Targeting the Leukemic stem cell protein machinery by inhibition of mitochondrial pyrimidine synthesis117
Targeting conformational changes in C‐reactive protein to inhibit pro‐inflammatory actions97
HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy89
Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7 ‐deficient cells86
Elongator and the role of its subcomplexes in human diseases78
A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability74
Depressive patient‐derived GABA interneurons reveal abnormal neural activity associated with HTR2C73
Targetable Brg1‐CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking64
Metformin rescues migratory deficits of cells derived from patients with periventricular heterotopia63
TFEB and TFE3 drive kidney cystogenesis and tumorigenesis63
ASO targeting RBM3 temperature‐controlled poison exon splicing prevents neurodegeneration in vi62
Diagnostic biomarkers for active tuberculosis: progress and challenges61
Molecular and cognitive signatures of ageing partially restored through synthetic delivery of IL2 to the brain60
Systemic inflammation after stroke: implications for post‐stroke comorbidities58
Eosinophil‐derived IL ‐4 is necessary to establish the inflammatory structure in innate inflammation57
Nerve regeneration by interferon intervention in aging brain53
Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy51
Single‐cell profiling of muscle‐infiltrating T cells in idiopathic inflammatory myopathies51
Shear stress control of vascular leaks and atheromas through Tie2 activation by VE‐PTP sequestration50
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination49
Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model49
Looking at a baby's heart through the lens of the mother's blood48
Functions of double‐negative B cells in autoimmune diseases, infections, and cancers48
ALX1 ‐related frontonasal dysplasia results from defective neural crest cell development and migration47
Macrophage colony‐stimulating factor as a weapon against cytomegalovirus47
Optimizing the Cas13 antiviral train: cargo and delivery47
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using 46
Blocking STAT3 /5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma45
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV 45
In vivo single‐cell transcriptomics reveal Klebsiella pneumoniae skews lung macrophages to promote infection44
A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy43
Advances in high‐throughput mass spectrometry in drug discovery42
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis41
Mitochondrial HSF1 triggers mitochondrial dysfunction and neurodegeneration in Huntington's disease41
Sex differences and risk factors for bleeding in Alagille syndrome40
The human host response to monkeypox infection: a proteomic case series study40
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL39
0.2093870639801